Pandemic Impacts in the Workplace: Employee Wellness, Returning to the Office, & Remote Testimony

Pandemic Impacts in the Workplace: Employee Wellness, Returning to the Office, & Remote Testimony

← Back to ASCLD Train the Director Series

This webinar originally occurred on April 12, 2022
Duration: 1 hour


Employers have endured many operational changes due to the pandemic. During the pandemic, employers have faced numerous challenges, such as how to help adjust to and embrace operational change, while still providing good customer service and prompt responsiveness. In addition, employers have had to find ways to increase employee interactions virtually to forge connections and effective collaboration in a remote or hybrid environment.

As the pandemic has evolved, some employers are bringing employees back into the office. Whether employers require full-time hours in the office or opt to develop hybrid programs, supervisors are starting to experience new challenges. Employers who plan to bring employees back into the office risk potentially losing members of their workforce to other occupations that offer complete remote work due to a lingering fear of being exposed to the virus.

Advances in videoconferencing platforms have changed the work environment and allowed for the expanded use of remote testimony in court proceedings. To continue operations and ensure the safety of all participants during the pandemic, many courts turned to remote testimony. Now, courts are continuing to utilize remote testimony to optimize judicial efficiency; however, some constitutional barriers remain.

This webinar will discuss the impact that the pandemic has had on the physical and emotional wellbeing of employees in the laboratory setting as well as personnel issues that workplaces may experience following the pandemic. The presenters will also discuss ways to best care for employees as we try to return to a post-pandemic world and will explore the utilization and expansion of remote testimony in court proceedings.

Detailed Learning Objectives

  1. Attendees will learn about the pandemic’s impact on employee physical and mental health and how agencies can support employees.
  2. Attendees will be able to identify personnel issues that can occur while making changes to an employee’s work environment and develop strategies to assist with change.
  3. Attendees will learn about the constitutional limitations on remote testimony and how it affects employees.


  • Angie Jones | Wellness Coordinator, Kansas Bureau of Investigation
  • Jessica Domme | Assistant Attorney General, Kansas Office of the Attorney General
  • Kristin Feeback, PsyD | President/CEO, CommCare, Kansas City, MO 

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at with any questions and subscribe to our newsletter for notifications.

Related Content

A Landscape Study of Computed Tomography Scanners for Postmortem Applications

Date December 2023 Overview Advanced imaging technologies help medicolegal death investigation (MDI) personnel assess cause of death (COD) and manner of death (MOD). The Medical Examiner and Coroner (MEC) community utilize postmortem computed tomography (PMCT) to obtain imaging data to…

FLN-TWG: A Roadmap to Improve Research and Technology Transition in Forensic Science

← Back to FLN-TWG Main Page  Forensic Laboratory Needs Technology Working Group (FLN-TWG) The National Institute of Justice (NIJ), in partnership with the Forensic Technology Center of Excellence (FTCOE) at RTI International, formed the Forensic Laboratory Needs Technology Working Group…

FTCOE White Box Seized Drugs Interlaboratory Comparison Study

Overview The Forensic Technology Center of Excellence (FTCOE) funded by the National Institute of Justice (NIJ, 15PNIJ-21-GK-02192-MUMU) is conducting a research evaluation of analytical schemes used within seized drug chemistry. The purpose of this study is to evaluate the performance…